Orphan nuclear receptors: From new ligand discovery technologies to novel signaling pathways

Current Opinion in Drug Discovery and Development

Volumn 4, Issue 5, 2001, Pages 575-590

  Shiau, A K ^a   Coward, P ^a   Schwarz, M ^a   Lehmann, J M ^a  

^a AMGEN INC   (United States)

Author keywords

Estrogen receptor related receptor; Farnesoid X receptor; Fluorescence polarization; Fluorescence resonance energy transfer; Homogeneous time resolved fluorescence; Liver X receptor

Indexed keywords

22 HYDROXYCHOLESTEROL; 4 HYDROXYTAMOXIFEN; ARACHIDONIC ACID; BILE ACID; CELL NUCLEUS RECEPTOR; CHOLESTEROL DERIVATIVE; DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; LIGAND; TRANSCRIPTION FACTOR; CELL RECEPTOR; FARNESOID X RECEPTOR LIKE ORPHAN RECEPTOR; FARNESOID X RECEPTOR-LIKE ORPHAN RECEPTOR; LXRALPHA PROTEIN;

AGONIST; ASSAY; CELL DIFFERENTIATION; DEVELOPMENT; ENERGY TRANSFER; FLUORESCENCE; HOMEOSTASIS; HUMAN; POLARIZATION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG DESIGN; DRUG EFFECT; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMAL; DRUG DESIGN; HUMAN; LIGANDS; MOLECULAR SEQUENCE DATA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 0034807224     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (141)

1. The steroid and thyroid hormone receptor superfamily
2. The nuclear receptor superfamily: The second decade
3. The RXR heterodimers and orphan receptors
4. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?
5. Steroid hormone receptors: Many actors in search of a plot
6. Nuclear Receptor Nomenclature Committee A unified nomenclature system for the nuclear receptor superfamily
7. Selective estrogen receptor modulators: Clinical spectrum
8. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
9. Bexarotene ligand pharmaceuticals
10. Orphan nuclear receptors - New ligands and new possibilities
11. Orphan nuclear receptors: From gene to function
12. The PPARs: From orphan receptors to drug discovery
13. Orphan nuclear receptors: Shifting endocrinology into reverse
14. Nuclear hormone receptors as targets for new drug discovery
15. Development of a scintillation proximity assay for peroxisome proliferator-activated receptor γ ligand binding domain
16. An ultrahigh-throughput screening assay for estrogen receptor ligands
17. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis
18. The coregulator exchange in transcriptional functions of nuclear receptors
19. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
20. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
21. Androstane metabolites bind to and deactivate the nuclear receptor CAR-β
22. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
23. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
24. Fluorescence resonance energy transfer
25. Time-resolved fluorescence spectroscopy
26. Homogeneous fluorescence readouts for miniaturized high-throughput screening: Theory and practice
27. Nuclear receptors have distinct affinities for coactivators: Characterization by fluorescence resonance energy transfer
28. Nuclear-receptor ligands and ligand-binding domains
29. Binding of ligands and activation of transcription by nuclear receptors
30. Bile acids: Natural ligands for an orphan nuclear receptor
31. Identification of a nuclear receptor for bile acids
32. Identification of a chemical tool for the orphan nuclear receptor FXR
33. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands
34. Pharmacophore analysis of the nuclear oxysterol receptor LXRα
35. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γ
36. Fluorescence anisotropy: Rapid, quantitative assay for protein-DNA and protein-protein interaction
37. Fluorescence anisotropy applied to biomolecular interactions
38. Fluorescence polarization - A new tool for cell and molecular biology
39. Role of LXRs in control of lipogenesis
40. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR
41. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily
42. LXR, a nuclear receptor that defines a distinct retinoid response pathway
43. Ubiquitous receptor: A receptor that modulates gene activation by retinoic acid and thyroid hormone receptors
44. NER, a new member of the gene family encoding the human steroid hormone nuclear receptor
45. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor
46. Isolation of proteins that interact specifically with the retinoid X receptor: Two novel orphan receptors
47. An oxysterol signalling pathway mediated by the nuclear receptor LXRα
48. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
49. The orphan nuclear receptor LXRα is positively and negatively regulated by distinct products of mevalonate metabolism
50. Oxysterols: Modulators of cholesterol metabolism and other processes
51. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
52. Selective activation of liver X receptor α by 6α-hydroxy bile acids and analogs
53. Cholestenoic acid is a naturally occurring ligand for liver X receptor α
54. Auto-oxidized cholesterol sulfates are antagonistic ligands of liver X receptors: Implications for the development and treatment of atherosclerosis
55. Bile acid biosynthesis
56. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXRα
57. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXR β-deficient mice
58. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
59. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
60. Structure, function and regulation of the ABC1 gene product
61. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1
62. Transport of lipids from golgi to plasma membrane is defective in Tangier disease patients and ABC1-deficient mice
63. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
64. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
65. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
66. Human ABCA1 BAC transgenic mice show increased HDL-C and ApoAI dependent efflux stimulated by an internal promoter containing LXREs in intron 1
67. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR
68. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor
69. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
70. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols
71. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
72. Plasma lipid transfer proteins
73. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes
74. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
75. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
76. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
77. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption
78. Genetic basis of sitosterolemia
79. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene
80. Isoform 1c of sterol regulatory element binding protein is less active than isoform la in livers of transgenic mice and in cultured cells
81. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
82. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter
83. Atherosclerosis. The road ahead
84. Serum triglycerides, the liver and the pancreas
85. Fibrates, dyslipoproteinaemia and cardiovascular disease
86. Identification of a nuclear receptor that is activated by farnesol metabolites
87. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
88. Molecular genetics and regulation of bile acid biosynthesis
89. Bile acid transport
90. Nuclear orphan receptors control cholesterol catabolism
91. Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7α-hydroxylase transcription
92. Farnesoid X receptor responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription
93. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors
94. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
95. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
96. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences
97. The α1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family
98. CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7α-hydroxylase gene
99. Molecular cloning and expression of rabbit sterol 12α-hydroxylase
100. α1-Fetoprotein transcription factor is required for the expression of sterol 12α-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription
101. Don't know much bileology
102. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
103. Human bile salt export pump (BSEP) promoter is transactivated by the farnesoid X receptor/bile acid receptor (FXR/BAR)
104. Regulation of expression of human intestinal bile acid-binding protein in Caco-2 cells
105. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer
106. The orphan nuclear receptor, SHP, mediates bile acid-induced inhibition of the rat bile acid transporter, NTCP
107. Interleukin-1β suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation
108. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
109. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
110. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor
111. The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor
112. Activation of the orphan receptor RIP14 by retinoids
113. 3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties
114. The nuclear receptors FXR and LXRα: Potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases
115. The pregnane X receptor: A promiscuous xenobiotic receptor that has diverged during evolution
116. The human nuclear xenobiotic receptor PXR: Structural determinants of directed promiscuity
117. Chenodeoxycholic acid: A review of its pharmacological properties and therapeutic use
118. Molecular pathogenesis of cholestasis
119. Identification of a new class of steroid hormone receptors
120. Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41
121. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3
122. Identification of two hERR2-related novel nuclear receptors utilizing bioinformatics and inverse PCR
123. Human ERRγ, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: Tissue-specific isoforms are expressed during development and in the adult
124. The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene
125. The ERR-1 orphan receptor is a transcriptional activator expressed during bone development
126. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERRβ
127. Estrogen-related receptor α1 functionally binds as a monomer to extended half-site sequences including ones contained within estrogen-response elements
128. Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter
129. Modulation of aromatase expression in the breast tissue by ERR α-1 orphan receptor
130. Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related α
131. A role for estrogen-related receptor α in the control of mitochondrial fatty acid β-oxidation during brown adipocyte differentiation
132. Activation of the thyroid hormone receptor α gene promoter by the orphan nuclear receptor ERRα
133. Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) α, but not by ERβ
134. Transcriptional activities of the orphan nuclear receptor ERR α (estrogen receptor-related receptor-α)
135. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2
136. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERRβ
137. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
138. Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor α-1 orphan receptor
139. Molecular basis for the constitutive activity of estrogen related receptor α-1 (ERRα-1)
140. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β